Kamil R. Kranc

4.1k citations

41 papers · 2.1k indexed · 1 hit paper · h-index 20

Hematology top 2%
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 9
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
Immunology top 5%
- Immunotherapy and Immune Responses 5
Molecular Biology top 10%
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 5
- RNA Research and Splicing 5
Aging top 10%
Cell Biology
- Zebrafish Biomedical Research Applications 3

Co-authors: Sten Eirik W. Jacobsen Simon D. Bamforth Shoumo Bhattacharya José Bragança Anna Katharina Simon Gordana Djordjević Michael Lutteropp Elizabeth J. Soilleux
Cited by: Hematology Cancer Research Immunology
Journals: Nature (1 paper)Nature Communications (1 paper)Nature Genetics (1 paper)
Partner nations: United Kingdom Germany United States

In The Last Decade

Kamil R. Kranc

40 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kamil R. Kranc

Since Specialization

Citations

This map shows the geographic impact of Kamil R. Kranc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamil R. Kranc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamil R. Kranc more than expected).

Fields of papers citing papers by Kamil R. Kranc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamil R. Kranc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamil R. Kranc. The network helps show where Kamil R. Kranc may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kamil R. Kranc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kamil R. Kranc Line = papers co-authored together Kamil R. Kranc links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impaired DNA damage responses and inflammatory signaling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency Stem Cell Reports ·Ali Abdelfattah,Ahmad Habib,Leigh-anne Thomas,Juan Bautista Menendez-Gonzalez,Alhomidi Almotiri,Hind Alqahtani,Hannah Lawson,Sarab Taha,Millie Steadman,Radhika Athalye,Alex Gibbs,Hamed Alzahrani,Ali Alshahrani,Alice Cato,Peter Giles,Alex Tonks,Ashleigh S. Boyd,Kamil R. Kranc,Neil P. Rodrigues	2025	0
2	Dissecting infant leukemia developmental origins with a hemogenic gastruloid model eLife ·Denise Ragusa,Chun-Wai Suen,Gabriel Torregrosa,Fabio Pastorino,Ayona Johns,Ylenia Cicirò,Liza Dijkhuis,Susanne van den Brink,Michele Cilli,Connor Byrne,G. Ionescu,Joana Cerveira,Kamil R. Kranc,Víctor Hernández-Hernández,Mirco Ponzoni,Anna Bigas,Jordi García‐Ojalvo,Alfonso Martínez Arias,Cristina Pina	2025	1
3	Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient‐derived xenografts HemaSphere ·Vilma Dembitz,Jozef Durko,Joana Campos,Sophie C. James,Hannah Lawson,Kamil R. Kranc,Paolo Gallipoli	2024	2
4	Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death Nature Communications ·Keith Woodley,Laura S Dillingh,George Giotopoulos,Pedro Madrigal,Kevin M. Rattigan,Céline Philippe,Vilma Dembitz,Aoife M. S. Magee,Ryan Asby,Louie N. van de Lagemaat,Christopher Mapperley,Sophie C. James,Jochen H.M. Prehn,Konstantinos Tzelepis,Kevin Rouault‐Pierre,George S. Vassiliou,Kamil R. Kranc,G. Vignir Helgason,Brian J.P. Huntly,Paolo Gallipoli	2023	14
5	Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders Blood Reviews ·Vishaka Gorur,Kamil R. Kranc,Miguel Ganuza,Paul Telfer	2023	3
6	m6A RNA modifications: Key regulators of normal and malignant hematopoiesis Experimental Hematology ·Pia Sommerkamp,Jessie Brown,Myriam Haltalli,François Mercier,Ly Vu,Kamil R. Kranc	2022	1
7	A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells eLife ·David J. Turner,Alexander Saveliev,Fiamma Salerno,Louise S. Matheson,Michael Screen,Hannah Lawson,David Wotherspoon,Kamil R. Kranc,Martin Turner	2022	12
8	NANOS2 is a sequence-specific mRNA-binding protein that promotes transcript degradation in spermatogonial stem cells iScience ·Azzurra Codino,Tomasz W. Turowski,Louie N. van de Lagemaat,Ivayla Ivanova,Andrea Tavosanis,Christian Much,Tania Auchynnikava,Lina Vasiliauskaitė,Marcos Morgan,Juri Rappsilber,Robin C. Allshire,Kamil R. Kranc,David Tollervey,Dónal O’Carroll	2021	12
9	CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation Stem Cell Reports ·Hannah Lawson,Louie N. van de Lagemaat,Melania Barile,Andrea Tavosanis,Jozef Durko,Arnaud Villacreces,Aarushi Bellani,Christopher Mapperley,Elise Georges,Catarina Martins‐Costa,Catarina Sepúlveda,Lewis Allen,Joana Campos,Kirsteen J. Campbell,Dónal O’Carroll,Berthold Göttgens,Suzanne Cory,Neil P. Rodrigues,Amélie V. Guitart,Kamil R. Kranc	2021	10
10	Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms Leukemia ·Julian Baumeister,Nicolas Chatain,Annika Hubrich,Tiago Maié,Ivan G. Costa,Bernd Denecke,Lijuan Han,Caroline Küstermann,Stephanie Sontag,Kristin Seré,Klaus Strathmann,Martin Zenke,Andreas Schuppert,Tim H. Brümmendorf,Kamil R. Kranc,Steffen Koschmieder,Deniz Gezer	2019	41
11	Machine Learning Enables Live Label-Free Phenotypic Screening in Three Dimensions Assay and Drug Development Technologies ·Eoghan O’Duibhir,J Paris,Hannah Lawson,Catarina Sepúlveda,Dahlia Doughty Shenton,Neil O. Carragher,Kamil R. Kranc	2018	8
12	hsa-mir183/EGR1–mediated regulation of E2F1 is required for CML stem/progenitor cell survival Blood ·Francesca Pellicano,Laura Park,Lisa Hopcroft,Mansi M. Shah,Lorna Jackson,Mary T. Scott,Cassie J. Clarke,Amy Sinclair,Sheela A. Abraham,Alan Hair,G. Vignir Helgason,Mark Aspinall-O’Dea,Ravi Bhatia,Gustavo Leone,Kamil R. Kranc,Anthony D. Whetton,Tessa L. Holyoake	2018	33
13	Condensin II mutation causes T-cell lymphoma through tissue-specific genome instability Genes & Development ·Jessica Woodward,Gillian C.A. Taylor,Dinesh C. Soares,Shelagh Boyle,Daoud Sie,David Read,Keerthi T. Chathoth,Milica Vukovic,Núria Tarrats,David Jamieson,Kirsteen J. Campbell,Karen Blyth,Juan Carlos Acosta,Bauke Ylstra,Mark J. Arends,Kamil R. Kranc,Andrew P. Jackson,Wendy A. Bickmore,Andrew J. Wood	2016	33
14	The role of 2-oxoglutarate dependent dioxygenases in normal haematopoiesis and acute myeloid leukemia Haematologica ·Catarina Sepulveda,Amélie V. Guitart,Milica Vukovic,Theano I. Panagopoulou,L. Allen,A Lengelling,Peter J. Ratcliffe,Kamil R. Kranc	2015	2
15	Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism PubMed ·Patrick J. Pollard,Ming Yang,Huizhong Su,Tomoyoshi Soga,Kamil R. Kranc	2014	48
16	T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides Immunity ·Maria Harkiolaki,Samantha L. Holmes,Pia Svendsen,Jon Waarst Gregersen,Lise Torp Jensen,Róisín M. McMahon,Manuel A. Friese,Gijs van Boxel,Ruth Etzensperger,John S. Tzartos,Kamil R. Kranc,Sarah Sainsbury,Karl Harlos,Elizabeth Mellins,Jackie Palace,Margaret M. Esiri,P. Anton van der Merwe,E. Yvonne Jones,Lars Fugger	2009	2
17	T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides (DOI:10.1016/j.immuni.2009.01.009) Immunity ·Maria Harkiolaki,Samantha L. Holmes,P. Svendsen,Jon Waarst Gregersen,L Jensen,Róisín M. McMahon,Michael Friese,Gijs van Boxel,Ruth Etzensperger,John S. Tzartos,Kamil R. Kranc,Sarah Sainsbury,Karl Harlos,Mellins,Jacqueline Palace,M M Esiri,P. Anton van der Merwe,E. Yvonne Jones,Lars Fugger	2009	5
18	Functional epistasis on a common MHC haplotype associated with multiple sclerosis Nature ·Jon Waarst Gregersen,Kamil R. Kranc,Xiayi Ke,Pia Svendsen,Lars Siim Madsen,Allan Randrup Thomsen,Lon R. Cardon,John I. Bell,Lars Fugger	2006	154
19	Control of autoimmunity by ?epitope theft? Trends in Molecular Medicine ·Kamil R. Kranc,Andrew J. Taylor,Nicholas Willcox,Lars Fugger	2004	2
20	Oxidative degradation of bilirubin produces vasoactive compounds European Journal of Biochemistry ·Kamil R. Kranc,Gail J. Pyne,Limei Tao,Timothy D. W. Claridge,David A. Harris,Thomas A.D. Cadoux-Hudson,Jonathan J. Turnbull,Christopher J. Schofield,Joseph F. Clark	2000	77

About Kamil R. Kranc

Kamil R. Kranc is a scholar working on Hematology, Genetics and Aging, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers), Epigenetics and DNA Methylation (7 papers), Immunotherapy and Immune Responses (5 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (5 papers), Zebrafish Biomedical Research Applications (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Hematology (479 citations), Cancer Research (388 citations) and Immunology (446 citations). Kamil R. Kranc has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Sten Eirik W. Jacobsen, Simon D. Bamforth, Shoumo Bhattacharya, José Bragança, Anna Katharina Simon, Gordana Djordjević, Michael Lutteropp, Elizabeth J. Soilleux, Amanda J. Stranks and Samantha J.L. Knight. Their work appears in journals such as Nature, Nature Communications and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact